J. Hong

A randomized, double-blind, single-dose, phase 1 study comparing the pharmacokinetics, pharmacodynamics, safety, and immunogenicity of denosumab biosimilar CT‑P41 and reference denosumab in healthy males.

Anhye Kim, H. Yoo, J. Reginster, 2024, Expert opinion on biological therapy.

Pharmacokinetic Comparison of a Fixed-Dose Combination of Candesartan Cilexetil/Amlodipine/Atorvastatin Versus Co-administration of Individual Formulations in Healthy Participants

J. Sunwoo, Jae Hoon Kim, Ji Hye Song, 2024, Advances in therapy.

Distribution and elimination kinetics of midazolam and metabolites after post-resuscitation care: a prospective observational study

Y. In, H. Ahn, Yeonho You, 2024, Scientific reports.